echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Int J Rheum Dis: Long-term follow-up results show that surgery is still the best treatment for AL in patients with ankylosing spondylitis

    Int J Rheum Dis: Long-term follow-up results show that surgery is still the best treatment for AL in patients with ankylosing spondylitis

    • Last Update: 2021-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Ankylosing spondylitis (AS) is a well-known chronic inflammatory rheumatism that causes progressive damage to the spinal structure and restricted movement.


    From June 2011 to March 2018, researchers conducted a retrospective analysis of 48 consecutive AL cases, including 13 conservative treatments and 35 surgical treatments.


     

    As a result, the average overall follow-up time was (44.


    In summary, the results of the study show that surgery is still the best treatment for AL patients with ankylosing spondylitis, and the medium and long-term follow-up data prove its better clinical efficacy.


     

    Original source:

     

    Minhao Wu, et al.


    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.